open access

Vol 22, No 4 (2017)
Original research articles
Published online: 2017-07-01
Submitted: 2016-08-16
Get Citation

Spironolactone ameliorates the cardiovascular toxicity induced by concomitant trastuzumab and thoracic radiotherapy

Guler Yavas, Esin Celik, Cagdas Yavas, Cagdas Elsurer, Rengin Elsurer Afsar
DOI: 10.1016/j.rpor.2017.01.004
·
Rep Pract Oncol Radiother 2017;22(4):295-302.

open access

Vol 22, No 4 (2017)
Original research articles
Published online: 2017-07-01
Submitted: 2016-08-16

Abstract

Aim

We aimed to evaluate impact of spironolactone (S) on cardiovascular toxicity of concomitant use of radiotherapy (RT) and trastuzumab (T).

Background

S, an aldosterone receptor antagonist, is known to ameliorate the cardiac damage. S ameliorates anthracycline -induced cardiotoxicity, there is no data regarding to effect of S on both T and radiation-induced cardiotoxicity.

Materials/Methods

Eighty rats were divided into eight groups: group (G) 1 was defined as control group. G2, G3 and G4 were RT, S and T groups respectively. G5, G6, G7 and G8 were RT[[ce:hsp sp="0.25"/]]+[[ce:hsp sp="0.25"/]]T, T[[ce:hsp sp="0.25"/]]+[[ce:hsp sp="0.25"/]]S, RT[[ce:hsp sp="0.25"/]]+[[ce:hsp sp="0.25"/]]S and RT[[ce:hsp sp="0.25"/]]+[[ce:hsp sp="0.25"/]]T[[ce:hsp sp="0.25"/]]+[[ce:hsp sp="0.25"/]]S groups respectively. Rats were sacrificed at 6th hour; 21st and 100th days after RT. Heart and thoracic aorta samples were taken for microscopical examination.

Results

Cardiac inflammation and fibrosis scores and; TGF-β expression were not significantly different within study groups at 6th hour and 21st days of RT. By 100th days of RT fibrosis scores and TGF-β expression in cardiac samples were significantly different between study groups (p values were 0.004 and 0.002 respectively). Pair-wise comparisons revealed that both cardiac fibrosis scores and TGF-β expression levels were higher in G5 when compared to G8 (p values were 0.046 and 0.028 respectively). Moreover the TGF-β expression was higher in G5 when compared to G2 (p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.046). We could not demonstrate any significant differences with respect to inflammation, fibrosis and TGF-β expression in thoracic aorta samples between study groups.

Conclusions

Although S had a protective effect on cardiac tissue it had no protective effect on thoracic aorta when administered with RT[[ce:hsp sp="0.25"/]]+[[ce:hsp sp="0.25"/]]T.

Abstract

Aim

We aimed to evaluate impact of spironolactone (S) on cardiovascular toxicity of concomitant use of radiotherapy (RT) and trastuzumab (T).

Background

S, an aldosterone receptor antagonist, is known to ameliorate the cardiac damage. S ameliorates anthracycline -induced cardiotoxicity, there is no data regarding to effect of S on both T and radiation-induced cardiotoxicity.

Materials/Methods

Eighty rats were divided into eight groups: group (G) 1 was defined as control group. G2, G3 and G4 were RT, S and T groups respectively. G5, G6, G7 and G8 were RT[[ce:hsp sp="0.25"/]]+[[ce:hsp sp="0.25"/]]T, T[[ce:hsp sp="0.25"/]]+[[ce:hsp sp="0.25"/]]S, RT[[ce:hsp sp="0.25"/]]+[[ce:hsp sp="0.25"/]]S and RT[[ce:hsp sp="0.25"/]]+[[ce:hsp sp="0.25"/]]T[[ce:hsp sp="0.25"/]]+[[ce:hsp sp="0.25"/]]S groups respectively. Rats were sacrificed at 6th hour; 21st and 100th days after RT. Heart and thoracic aorta samples were taken for microscopical examination.

Results

Cardiac inflammation and fibrosis scores and; TGF-β expression were not significantly different within study groups at 6th hour and 21st days of RT. By 100th days of RT fibrosis scores and TGF-β expression in cardiac samples were significantly different between study groups (p values were 0.004 and 0.002 respectively). Pair-wise comparisons revealed that both cardiac fibrosis scores and TGF-β expression levels were higher in G5 when compared to G8 (p values were 0.046 and 0.028 respectively). Moreover the TGF-β expression was higher in G5 when compared to G2 (p[[ce:hsp sp="0.25"/]]=[[ce:hsp sp="0.25"/]]0.046). We could not demonstrate any significant differences with respect to inflammation, fibrosis and TGF-β expression in thoracic aorta samples between study groups.

Conclusions

Although S had a protective effect on cardiac tissue it had no protective effect on thoracic aorta when administered with RT[[ce:hsp sp="0.25"/]]+[[ce:hsp sp="0.25"/]]T.

Get Citation

Keywords

Aldosterone; Cardiovascular toxicity; Radiotherapy; Spironolactone; Trastuzumab

About this article
Title

Spironolactone ameliorates the cardiovascular toxicity induced by concomitant trastuzumab and thoracic radiotherapy

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 22, No 4 (2017)

Pages

295-302

Published online

2017-07-01

DOI

10.1016/j.rpor.2017.01.004

Bibliographic record

Rep Pract Oncol Radiother 2017;22(4):295-302.

Keywords

Aldosterone
Cardiovascular toxicity
Radiotherapy
Spironolactone
Trastuzumab

Authors

Guler Yavas
Esin Celik
Cagdas Yavas
Cagdas Elsurer
Rengin Elsurer Afsar

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl